471 A Microrna Network Mediates Chemoresistance in Colorectal Cancer Stem Cells

Shusuke Toden,Kunitoshi Shigeyasu,Yoshinaga Okugawa,Wenhao Weng,C. R. Boland,Ajay Goel

DOI: https://doi.org/10.1016/s0016-5085(16)30456-5

IF: 29.4

2016-01-01

Gastroenterology

Abstract:Background: One of the major underlying causes of mortality in colorectal cancer (CRC) patients is intrinsic resistance to chemotherapy.Emerging evidence suggests that chemoresistance in cancers is linked to a subset of cancer cells termed "cancer stem cells" (CSCs), and splice variants of CD44, in particular v6, are associated with a more aggressive subset of CSCs in CRC.Although microRNAs (miRNAs) are known for their central role in selfrenewal, the molecular mechanisms by which miRNAs regulate an aggressive CSC population remains unexplored.Aims: We aimed to characterize CD44v6-positive CSCs, their role in mediating chemoresistance, and their clinical significance in CRC.Furthermore, we interrogated the miRNA network associated with CD44v6 phenotype in CSCs.Methods: The oncogenic and chemoresistant roles of CD44v6 were assessed by siRNA-mediated knockdown in CRC cell lines and spheroid-derived CSCs (SDCSCs).CD44v6 + /CD44v6 - cells were isolated from SDCSCs and their cellular functions were determined in vitro and in vivo.The clinical significance of CD44v6 was also assessed in two independent clinical patient cohorts.MiRNA-Seq was used to profile CD44v6 + /CD44v6 - SDCSC populations to establish the miRNAnetwork and identify potential miRNA-based therapeutic targets.Results: Over-expression of CD44v6 was confirmed in both chemoresistant CRC cell lines and SDCSCs.Inhibition of CD44v6 resulted in suppressed self-renewal capacity and enhanced sensitivity to chemotherapeutic drugs.Within the SDCSC population, CD44v6 + CSCs showed significantly higher spheroid and colony-forming ability and higher resistance to chemotherapeutic drugs compared to CD44v6 - CSCs.In vivo limiting dilution transplantation assays revealed that CD44v6 +CSCs have remarkably higher tumor initiation ability.Clinically, CD44v6 expression was upregulated in a stage-dependent manner in primary CRCs, and high CD44v6 expression resulted in poorer disease-free and overall survival.MiRNA profiling identified a unique pattern of CD44v6+ SDCSCs indicative of high self-renewal capacity.We discovered that a panel of self-renewal-suppressive miRNAs was downregulated (including miR-34a and miR-101), along with concurrent upregulation of key oncogenic miRNAs (including miR-22 and miR-27) in CD44v6 + CSCs.Conclusion: Collectively, we provide the first evidence that CD44v6 + CSCs are critical mediators of enhanced chemoresistance and tumorigenicity in CRC cells.These findings were further corroborated through associations between high CD44v6 expression and poor prognosis in CRC patients.From a mechanistic viewpoint, we identified a network of dysregulated miRNAs that mediated chemoresistance in CSCs, thus providing a compelling rationale for therapeutic targeting of miRNAs as a potential strategy for overcoming chemoresistance and improved therapeutic response in patients with CRC.